Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STEREOSELECTIVE INTERACTION' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Srinivas, NR; Barbhaiya, RH; Midha, KK
      Enantiomeric drug development: Issues, considerations, and regulatory requirements

      JOURNAL OF PHARMACEUTICAL SCIENCES
    2. Thijssen, HH; Flinois, JP; Beaune, PH
      Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes

      DRUG METABOLISM AND DISPOSITION
    3. Niopas, I; Toon, S; Aarons, L; Rowland, M
      The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    4. MINERS JO; BIRKETT DJ
      CYTOCHROME P4502C9 - AN ENZYME OF MAJOR IMPORTANCE IN HUMAN DRUG-METABOLISM

      British journal of clinical pharmacology
    5. ANGELI P
      PENTATOMIC CYCLIC ANTAGONISTS AND MUSCARINIC RECEPTORS - A 30-YEAR REVIEW

      Il Farmaco
    6. CUPP MJ; TRACY TS
      CYTOCHROME-P450 - NEW NOMENCLATURE AND CLINICAL IMPLICATIONS

      American family physician
    7. CROPP JS; BUSSEY HI
      A REVIEW OF ENZYME-INDUCTION OF WARFARIN METABOLISM WITH RECOMMENDATIONS FOR PATIENT-MANAGEMENT

      Pharmacotherapy
    8. KAMINSKY LS; ZHANG ZY
      HUMAN P450 METABOLISM OF WARFARIN

      Pharmacology & therapeutics
    9. MAILLOUX AT; GIDAL BE; SORKNESS CA
      POTENTIAL INTERACTION BETWEEN WARFARIN AND DICLOXACILLIN

      The Annals of pharmacotherapy
    10. OGUNI K; ITO M; ISOKAWA A; MATSUMOTO A
      C-13 NUCLEAR SPIN-SPIN RELAXATION-TIMES (T(2C)S) OF ENANTIOMERS IN THE PRESENCE OF COLUMN PACKING MATERIAL AND SOLVENTS FOR CHIRAL DISCRIMINATION HPLC

      Chirality
    11. HARDER S; THURMANN P
      CLINICALLY IMPORTANT DRUG-INTERACTIONS WITH ANTICOAGULANTS - AN UPDATE

      Clinical pharmacokinetics
    12. PIFFERI G; PERUCCA E
      THE COST-BENEFIT RATIO OF ENANTIOMERIC DRUGS

      European journal of drug metabolism and pharmacokinetics
    13. MEYER BH; MULLER FO; BADENHORST PN; LUUS HG; DELAREY N
      MULTIPLE DOSES OF TRANDOLAPRIL DO NOT AFFECT WARFARIN PHARMACODYNAMICS

      South African medical journal
    14. GIDAL BE; SORKNESS CA; MCGILL KA; LARSON R; LEVINE RR
      EVALUATION OF A POTENTIAL ENANTIOSELECTIVE INTERACTION BETWEEN TICLOPIDINE AND WARFARIN IN CHRONICALLY ANTICOAGULATED PATIENTS

      Therapeutic drug monitoring
    15. VANSCOY GJ; COAX WC
      ORAL ANTICOAGULATION - IMPROVING THE RISK-BENEFIT RATIO

      Journal of family practice
    16. HORN JR; HANSTEN PD
      DRUG-INTERACTIONS WITH ANTIBACTERIAL AGENTS

      Journal of family practice
    17. KONG ANT; TOMASKO L; WALDMAN SA; OSBORNE B; DEUTSCH PJ; GOLDBERG MR; BJORNSSON TD
      LOSARTAN DOES NOT AFFECT THE PHARMACOKINETICS AND PHARMACODYNAMICS OFWARFARIN

      Journal of clinical pharmacology
    18. GARCIA B; LACAMBRA C; GARROTE F; GARCIAPLAZA I; SOLIS J
      POSSIBLE POTENTIATION OF ANTICOAGULANT EFFECT OF ACENOCOUMAROL BY OMEPRAZOLE

      Pharmacy world & science
    19. CHAN E; MCLACHLAN A; OREILLY R; ROWLAND M
      STEREOCHEMICAL ASPECTS OF WARFARIN DRUG-INTERACTIONS - USE OF A COMBINED PHARMACOKINETIC-PHARMACODYNAMIC MODEL

      Clinical pharmacology and therapeutics
    20. ERMER JC; HICKS DR; WHEELER SC; KRAML M; JUSKO WJ
      CONCOMITANT ETODOLAC AFFECTS NEITHER THE UNBOUND CLEARANCE NOR THE PHARMACOLOGICAL EFFECT OF WARFARIN

      Clinical pharmacology and therapeutics
    21. WELLS PS; HOLBROOK AM; CROWTHER NR; HIRSH J
      INTERACTIONS OF WARFARIN WITH DRUGS AND FOOD

      Annals of internal medicine
    22. SJO P; AASEN AJ
      ANTICHOLINERGIC AGENTS .4. STEREOCONTROLLED SYNTHESIS OF FLUORINATED ACETYLCHOLINE ANTAGONISTS - SYNTHESES OF THE 2 LOHEXYL-1-(4-FLUOROPHENYL)-3-PIPERIDYL-1-PROPANOLS AND THEIR METHIODIDES

      Acta chemica Scandinavica
    23. GRIND M; MURPHY M; WARRINGTON S; ABERG J
      METHOD FOR STUDYING DRUG-WARFARIN INTERACTIONS

      Clinical pharmacology and therapeutics
    24. HERMANS JJR; THIJSSEN HHW
      HUMAN LIVER MICROSOMAL METABOLISM OF THE ENANTIOMERS OF WARFARIN AND ACENOCOUMAROL - P450 ISOZYME DIVERSITY DETERMINES THE DIFFERENCES IN THEIR PHARMACOKINETICS

      British Journal of Pharmacology
    25. SOTO J; SACRISTAN JA; ALSAR MJ; FERNANDEZVIADERO C; VERDUGA R
      PROBABLE ACENOCOUMAROL-AMOXICILLIN INTERACTION

      Acta haematologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 21:37:58